Bristol Myers Squibb and 2seventy bio Announce Topline Results from KarMMa-3 Trial Showing Abecma Significantly Improves Progression-Free Survival Versus Standard Regimens in Relapsed and Refractory Multiple Myeloma Pharmaceutical Investing
Johnson & Johnson to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference Pharmaceutical Investing
Gilead Sciences and a Coalition of LGBTQ+ and Human Rights-Focused Organizations Mobilize to Address Monkeypox Public Health Emergency Pharmaceutical Investing
Mathai Mammen, M.D., Ph.D., Leaves Position as Executive Vice President, Pharmaceuticals, R&D, Johnson & Johnson Pharmaceutical Investing
Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15 Life Science Investing
Pfizer to Acquire Global Blood Therapeutics for $5.4 Billion to Enhance Presence in Rare Hematology Life Science Investing
Myovant Sciences and Pfizer Receive U.S. FDA Approval of MYFEMBREE®, a Once-Daily Treatment for the Management of Moderate to Severe Pain Associated With Endometriosis Life Science Investing
Abbott and WeightWatchers Partner to Support People Living with Diabetes in Attaining their Health Goals Pharmaceutical Investing
